Aktuelles | 16-06-26 Kickoff for the EU-Pathfinder Project HEARTCORE at the NMI It goes without saying that new drug ingredients should put as little strain on the heart as possible. But how can potential effects be reliably predicted? In the HEARTCORE project, researchers – with the participation of the NMI – are developing solutions. continue reading
Aktuelles | 01-06-26 More precise therapeutic agents for neuropsychiatry: The NMI is helping to unravel complex receptor mechanisms How can effective treatments for neuropsychiatric disorders be developed without having to accept unwanted side effects? Researchers at the NMI have made an important contribution to this field and published their findings in a new paper. continue reading
Aktuelles | 27-05-26 Course on Material Compliance at the NMI MedicalMountains GmbH regularly offers training courses for medical device compliance managers – and is happy to draw on the expertise available at the NMI. Just like last week. continue reading
Aktuelles | 26-05-26 Biomarkers: What is currently happening in this field of research? Biomarkers hold great promise. In a joint workshop organized by the GBM Bioanalytics Study Group, SIGNATOPE GmbH, and the NMI, we will explore the latest developments on September 17 and 18. continue reading
Aktuelles | 06-05-26 BioDev Symposium at the NMI What does the future hold for Biologicals? And how can the BioDevCenter help bring them into clinical use more frequently? In today’s symposium, we addressed precisely these questions. continue reading
Press | 20-04-26 3D-Printed Tissue Substitute Dr. Hanna Hartmann of the NMI has collaborated with partners to develop biomimetic materials for biohybrid implants—a patent application has already been filed. For more information, see the latest press release from Fraunhofer IAP. continue reading